- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
A.L.I. acquisition reaches completion
McKesson announced July 8 the final acquisition of A.L.I. Technologies. The A.L.I. line of PACS products, now known as Horizon Medical Imaging, complements McKesson's Horizon Clinicals suite. Together, the two technologies will provide integrated access
McKesson announced July 8 the final acquisition of A.L.I. Technologies. The A.L.I. line of PACS products, now known as Horizon Medical Imaging, complements McKesson's Horizon Clinicals suite. Together, the two technologies will provide integrated access to the complete patient record. The goal behind the acquisition is to consolidate the technologies needed to automate and streamline workflow along every step of the diagnostic process from the time a test is ordered until the image is interpreted and the results are distributed to the referring physician, according to the company. The acquisition boosts McKesson's customer base to more than 500 installations. A.L.I. will be known as the McKesson Medical Imaging Group. Its employees will remain in the Vancouver, BC, location.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
